Samsara BioCapital’s Rocket Pharmaceuticals RCKT Stock Holding History

Samsara BioCapital’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,550	Closed	-$643K	–	60
2022 Q1	$643K	Hold	40,550	–	–	0.16%	51
2021 Q4	$885K	Hold	40,550	–	–	0.17%	47
2021 Q3	$1.21M	Hold	40,550	–	–	0.19%	45
2021 Q2	$1.8M	Sell	40,550 -23,220	-36%	-$1.01M	0.22%	45
2021 Q1	$2.83M	Hold	63,770	–	–	0.52%	37
2020 Q4	$3.5M	Sell	63,770 -35,873	-36%	-$1.31M	0.35%	26
2020 Q3	$2.28M	Sell	99,643 -38,554	-28%	-$950K	0.64%	27
2020 Q2	$2.89M	Buy	138,197 +10,000	+8%	+$180K	0.93%	23
2020 Q1	$1.79M	Buy	+128,197	New	+$2.54M	1.03%	20

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Samsara BioCapital's RCKT Position: Q2 2022 in Review

Samsara BioCapital sold out of Rocket Pharmaceuticals (RCKT) in Q2 2022, closing a stake of 40,550 shares — an estimated $643K sold.

Samsara BioCapital first reported a position in RCKT in Q1 2020 and held it in 9 quarters. The position peaked at $3.5M in Q4 2020. 147 funds tracked by Wall St. Rank hold RCKT as of Q2 2022.

Samsara BioCapital reported no remaining Rocket Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Samsara BioCapital sold 40,550 Rocket Pharmaceuticals shares in Q2 2022, an estimated $643K.
Samsara BioCapital first reported a position in Rocket Pharmaceuticals in Q1 2020 and held it in 9 quarters.
Samsara BioCapital's Rocket Pharmaceuticals position peaked at $3.5M in Q4 2020.
147 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2022.

Based on Samsara BioCapital's 13F filing for Q2 2022, filed 15 Aug 2022.